"Angesichts des Coronavirus ist das Hanusch-Krankenhaus nur für dringend nötige medizinische Behandlungen und Notfälle geöffnet. Der Eingang erfolgt nur über den Pavillon 4 (Rettungszufahrt). Hier gibt es eine Zugangskontrolle (Fiebermessen und Kurzbefragung). Die Versorgung von Notfällen erfolgt nach der Zugangskontrolle in der neuen Zentralen Erstaufnahme Einheit. Patientinnen und Patienten, die als potentiell Covid-19 infiziert gelten und nicht als Notfall kategorisiert werden, werden an 1450 verwiesen. Im ganzen Haus ist Besuchsverbot! Falls Sie Fieber oder Husten haben und Kontakt zu einem Corona-Verdachtsfall hatten bzw. zuletzt in einem Risikogebiet waren, rufen Sie die Gesundheitsberatung 1450 oder den Ärztenotdienst 141."

During the past decade, Center of Hematology and Oncology, Hanusch-Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Center of Hematology and Oncology, Hanusch-Hospital" are "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Center of Hematology and Oncology, Hanusch-Hospital" in a lesser frequency.

Most popular intervention types in "Center of Hematology and Oncology, Hanusch-Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "All-trans retinoic acid" (2 trials), "Cytarabine" (2 trials), "Idarubicin" (2 trials), "Etoposid" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center of Hematology and Oncology, Hanusch-Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Center of Hematology and Oncology, Hanusch-Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Center of Hematology and Oncology, Hanusch-Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center of Hematology and Oncology, Hanusch-Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".